% | $
Quotes you view appear here for quick access.

Shire plc Message Board

  • faosto faosto Nov 3, 2006 9:33 PM Flag

    My guess: Shire will acquire Cephalon

    Provided that the FTC doesn't shoot down the deals CEPH cut with BRL, Cephalon is an attractive takover target and has complementary drugs to Shire's ADD franchise. CEphalon treats wakefulness and has a powerful array of pain and cancer drugs on the way. The combination, with deep roots in Europe, would put the merger into the mega-biotech class of 10+ billion dollar companies. I own both shares, so this is my little dream.